2023 annual financial data
Connect Biopharma Holdings 2023 Net income growth
Direct answer
Net income growth was 47.41%.
Operating income was -69,056,000 USD and net income was -62,106,000 USD.
Operating cash flow was -47,930,000 USD.
Get free Connect Biopharma Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -69,056,000 USD
- Net income
- -62,106,000 USD
- Operating cash flow
- -47,930,000 USD